BioCentury | Nov 5, 2020
Management Tracks

Rosén joins Horizon as CSO and R&D head; plus moves at Boehringer, Dr. Reddy’s, Mylan and more

...of business development.Relmada Therapeutics Inc. (OTCQX:RLMD) expanded its leadership team welcoming Paolo Manfredi as acting CSO and Marco...
BioCentury | Sep 22, 2020
Deals

Next up, NodThera? Roche’s €380M deal for Inflazome is latest NLRP3 takeout

...standing among the first crop of high profile venture-backed biotechs with NLRP3 inhibitors.According to Forbion’s Marco...
BioCentury | Aug 28, 2020
Regulation

Biotech may have side-stepped CFIUS’ worst case scenario

...Thom Tillis (R-N.C.), John Cornyn (R-Texas) and Marco...
BioCentury | Apr 10, 2020
Management Tracks

Shakeup at Arix; plus Emergent, AlloVir, Asklepios Bio, Morphic, Gritstone and more

...as head of medical affairs. Philipson was CMO of Trizell Holding S.A. Gadeta B.V. hired Marco...
BioCentury | Mar 21, 2020
Product Development

Under duress, biotechs will have to make hard decisions for patients and themselves about which trials to run

...it’s not easy to make them use an iPad,” he said. Scynexis Inc. (NASDAQ:SCYX) CEO Marco...
BioCentury | Sep 20, 2019
Politics & Policy

HHS to review CMS approach to national security risks

...Acting Inspector General Joanne Chiedi wrote in a letter to Sens. Charles Grassley (R-Iowa) and Marco...
BioCentury | Jul 15, 2019
Politics & Policy

July 15 P&P Quick Takes: Senate bills for antibiotic de-linkage, germline editing; plus site inspections and PK guidance

...and market exclusivity rights. Lawmakers call for consensus on germline editing Sens. Dianne Feinstein (D-Calif.), Marco...
BioCentury | Jun 25, 2019
Company News

WuXi AppTec raising U.S. profile to counter political attacks

...IP.” Hu attributed recent criticisms of Chinese life science companies from Sens. Chuck Grassley (R-Iowa), Marco...
...scrutiny could limit WuXi AppTec’s future investments in the U.S. Steve Usdin, Washington Editor WuXi AppTec Co. Ltd. Marco...
BioCentury | Jun 22, 2019
Financial News

WuXi stocks tumble as Rubio continues to press China agenda

...in Hong Kong on Friday, losing a combined $765 million in market cap, as Sen. Marco...
...Healthcare Ventures and Frontline BioVentures in 2017. Elizabeth S. Eaton, Staff Writer WuXi AppTec Co. Ltd. WuXi Biologics Inc. CFIUS DARPA Marco...
BioCentury | Jun 21, 2019
Politics, Policy & Law

Fearmongering about China diminishes American life sciences competitiveness

...means are necessary, legal or not, overt or covert, to achieve its goals.” Another senator, Marco...
...Washington Editor iCarbonX NIH PatientsLikeMe Inc. China Sen. Marco Rubio Sen. Chuck Grassley Sen. John Cornyn national security China national security Sen. Chuck Grassley Sen. John Cornyn Sen. Marco...
Items per page:
1 - 10 of 117